Montelukast Prescribing at STOKE SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
585
Total Quantity
20.1K
NHS Cost
£957
vs National Avg
-14.6%
STOKE SURGERY prescribed 585 items of Montelukast over the last 12 months at a cost of £957 to the NHS. This is 14.6% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
48
Jun 2026
50
Jun 2026
47
Jun 2026
57
Jun 2026
51
Jun 2026
45
Jun 2026
58
Jun 2026
50
Jun 2026
44
Jun 2026
44
Jun 2026
48
Jun 2026
43
Prescribing Details
| Total Items | 585 |
|---|---|
| Total Quantity | 20,083 |
| Total NHS Cost | £957 |
| Presentations | 4 different forms |
| vs National Average | -14.6% |
Montelukast Prescribing Comparison
| This practice | 585 items |
|---|---|
| National average per practice | 685 items |
| Difference | -14.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.